Jiang Shibo's Personal Achievements

Professor Jiang Shibo has been engaged in the research of antiviral drugs and vaccines for many years, and is one of the first researchers in the world to participate in the research and development of anti-HIV microbicides. He is the discoverer of the prototype of the anti-HIV polypeptide drug, Enveloptide, and has opened up a new field of research and development of anti-virus polypeptide drugs and virus fusion inhibitors. Professor Jiang Shibo has published more than 265,438+00 SCI papers, with an average impact factor of more than 5, including Nature, Natural Medicine, Nature Review Microbiology, The Lancet, Cell, PNAS, etc., and has been cited more than 5,000 times. Professor Jiang Shibo has applied for 23 patents (authorized patents 13) in the United States, and obtained NIH research fund 12 (7 for PI and 5 for Co-PI), cooperative research fund for overseas young scholars of National Natural Science Foundation of China 1 (Jieqing Class B), and other countries, ministries and municipalities. .